Jeffrey M. Dayno - Jan 24, 2024 Form 4 Insider Report for Harmony Biosciences Holdings, Inc. (HRMY)

Role
PRESIDENT, CEO, Director
Signature
/s/ Christian Ulrich, Attorney-in-Fact
Stock symbol
HRMY
Transactions as of
Jan 24, 2024
Transactions value $
$0
Form type
4
Date filed
1/26/2024, 04:56 PM
Previous filing
May 31, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HRMY Stock Option Award $0 +202K $0.00 202K Jan 24, 2024 Common Stock 202K $30.69 Direct F1
transaction HRMY Restricted Stock Units Award $0 +42K $0.00 42K Jan 24, 2024 Common Stock 42K Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option vests with respect to 25% of the underlying shares on January 24, 2025, with the remaining shares vesting ratably on a quarterly basis thereafter until the fourth anniversary of the grant date, subject to the Reporting Person's continued service through each applicable vesting date.
F2 The restricted stock units shall vest in four equal annual installments beginning January 24, 2025, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date.